RegWardenFDA facility compliance records
Recall

Class II — Matrix Surgical Holdings, LLC

Recalling firmMatrix Surgical Holdings, LLC. dba Matrix Surgical USA
Registered facilityMATRIX SURGICAL HOLDINGS, LLC dba MATRIX SURGICAL USA (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonProduct mislabeling.
ProductOMNIPORE Surgical Implant Petite Paranasal - Right - Product Usage: OmniPore Surgical Implants in block, sheet, and anatomical shapes are intended for nonweight bearing applications of craniofacial reconstruction/cosmetic surgery and repair of craniofacial trauma. OmniPore Surgical Implants are also intended for the augmentation or restoration of contour in the craniomaxillofacial skeleton.
Quantity42
DistributionWorldwide distribution - US Nationwide distribution in the states of Florida and Massachusetts and countries of Argentina, Chile, Colombia, Iran, Mexico, Norway, Taiwan, and Turkey.
Initiated2019-01-30
Classified2019-04-26
Terminated2020-06-23
Recall numberZ-1224-2019
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Matrix Surgical Holdings, LLC (Z-1224-2019).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/82487/

Not open yet

Alerts for Matrix Surgical Holdings, LLC. dba Matrix Surgical USA

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.